Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xinlai Yao"'
Autor:
Chaping Cheng, Jinming Wang, Penghui Xu, Kai Zhang, Zhixiang Xin, Huifang Zhao, Zhongzhong Ji, Man Zhang, Deng Wang, Yuman He, Na Jing, Liancheng Fan, Kaiyuan Liu, Fei Li, Chengcheng Liu, Yiming Gong, Suli Cui, Zhe Sun, Di Sun, Xinlai Yao, Hongjun Li, Jian Zhang, Pengcheng Zhang, Baijun Dong, Wei Xue, Xueming Qian, Wei-Qiang Gao, Helen He Zhu
Publikováno v:
Nature Cancer. 3:565-580
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::034c58be6558638aba9c148c93f72c44
https://doi.org/10.1038/s43018-022-00380-3
https://doi.org/10.1038/s43018-022-00380-3
Autor:
Di Sun, Huanhuan Guo, Hongjun Li, Xinlai Yao, Yiqing Xu, Shenjie Zhang, Shijie Zhou, Xiaoli Zi, Lisa Zheng, Yi Gu, Xueming Qian
Publikováno v:
Cancer Research. 83:1546-1546
Regulatory T (Treg) cells are a distinctive lineage of CD4+ T cells as characterized by expression of FoxP3 and CD25 markers. Treg cells are involved in tumor development and progression by inhibiting antitumor immunity. Accumulation of Treg cells in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ce06818d04d350e491bbedce93bbe48
https://doi.org/10.1158/1538-7445.am2023-1546
https://doi.org/10.1158/1538-7445.am2023-1546
Autor:
Di Sun, Huanhuan Guo, Chaping Cheng, Hongjun Li, Xinlai Yao, Shuang Lu, Jie Ding, Shenjie Zhang, Shijie Zhou, Steven Yu, Yi Gu, Xueming Qian
Publikováno v:
Cancer Research. 83:465-465
Cancer associated fibroblast (CAF) is a rich source of factors for immune suppression and promotes cancer progression and metastasis via epithelial to mesenchymal transition (EMT). It is well known that tumors with mesenchymal phenotype have signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3521e90821a34c23724d30024037a071
https://doi.org/10.1158/1538-7445.am2023-465
https://doi.org/10.1158/1538-7445.am2023-465
Autor:
Huanhuan Guo, Xinlai Yao, Chunming Wang, Linlin Mao, Hongjun Li, Shuang Lu, Di Sun, Chengwei Jiang, Shenjie Zhang, Lisa Zheng, Fan Zhang, Fei Teng, Steven Yu, Yi Gu, Xueming Qian
Publikováno v:
Cancer Research. 82:6013-6013
Antibodies targeting PD1/PD-L1 are emerging as effective cancer immunotherapies, however, not all patients with PD-L1 expression respond to the treatment. A growing body of data demonstrates the pivotal roles of the master regulators from the tumor m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b2f48488bd9fe13c3e06abafbb9a171
https://doi.org/10.1158/1538-7445.am2022-6013
https://doi.org/10.1158/1538-7445.am2022-6013
Autor:
Chengwei Jiang, Xinlai Yao, Fan Zhang, Fei Teng, Zhenzhi Yan, Chunming Wang, Yi Gu, Shengjie Zhang, Yupeng Zhu, Xiwen Wu, Weiwei Sun, Huanhuan Guo, Yadong Dai, Di Sun, Yingdi Luo, Xiangyu Xu, Xueming Qian, Lisa Zheng, Hongjun Li
Publikováno v:
Cancer Research. 81:917-917
Treatment with immune checkpoint inhibitors, including anti-PD(L)-1 antibodies, has demonstrated durable responses in patients with PD-L1 expressing tumors. However, not all patients with PD-L1 expression respond to the treatment due to de novo or ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e90cfa6dce2aa978cbcf0627e1959878
https://doi.org/10.1158/1538-7445.am2021-917
https://doi.org/10.1158/1538-7445.am2021-917
Autor:
Timethy Liao, Francis Fan, Jerry Yang, Zhenzhi Yan, Xueming Qian, Huanhuan Guo, Zheng Dai, Hui Chai, Yi Gu, Xiaoli Zi, Fei Teng, Zhen Li, Lisa Zheng, Hongjun Li, Fei Xu, Xiwen Wu, Lei Shi, Xinlai Yao
Publikováno v:
Cancer Research. 80:5183-5183
Claudin-18 isoform 2 (CLDN18.2) is a member of the human claudin family of tetraspan membrane proteins that are crucial structural and functional components of tight junctions. Unlike other family members, CLDN18.2 expression is strictly limited to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d86d37b46f557d0fb855bfe8577857b3
https://doi.org/10.1158/1538-7445.am2020-5183
https://doi.org/10.1158/1538-7445.am2020-5183